Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Rectal Neoplasms × Drug Combinations × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 1 Margins of Excision 1

Interventions

Fluorouracil 51 Leucovorin 47 Oxaliplatin 41 Capecitabine 34 Irinotecan 24 Radiotherapy 15 Bevacizumab 15 Folfox protocol 11 Chemoradiotherapy 11 Neoadjuvant Therapy 9 Chemotherapy, Adjuvant 9 Cetuximab 8 Surgical Procedures, Operative 5 Drug Therapy 5 XELOX 4 Panitumumab 4 Laparoscopy 4 FOLFOXIRI protocol 4 Transanal Endoscopic Microsurgery 3 Radiation 3 Octreotide 3 IFL protocol 3 Floxuridine 3 Diathermy 3 Trinitrotoluene 2 Tegafur 2 Proctectomy 2 Occult Blood 2 Loperamide 2 Levamisole 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04389086 2022-09-06

PelvEx II

Catharina Ziekenhuis Eindhoven

Phase 3 Recruiting

Gastrointestinal

Margins of Excision, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡